News
Do you forget things often? Did you know it could be a precursor to Alzheimer’s dementia?
Forgetting your keys or an acquaintance's name from time to time is human. However, if memory lapses occur more...
Dementia is not just “one person’s diagnosis.”
It is a test for families, caregivers, healthcare and social systems – and above all for our ability to deal with...
Molecular Hydrogen Not Only Against Alzheimer’s Dementia — The Medicine of the Future
In this episode, Prof. Shigeo Ohta and David Maršálek, founder of H2 Global Group, return to the beginning of their...
Czechs Have a More Open Path to Investing in the “Medicine of the Future.” Why Capital Is Moving into MedTech, HealthTech, Mental Health, and Longevity
Just a few years ago, investments in healthcare and medical innovation were mainly opportunities for large funds, strategic players, and a narrow group of specialized investors. Today, the situation is changing rapidly. Healthcare is becoming one of the world’s main investment themes — not only because of returns, but also because of social necessity: aging populations, high household and public healthcare spending, shortages in care capacity, and the enormous burden placed on families caring for chronically ill relatives.
Molecular Hydrogen on the Path to Modern Medicine
A global problem without a simple solution Dementia and neurodegenerative diseases are among the greatest challenges...
The clinical study has been launched
Today in Ostrava, we initiated a clinical trial and enrolled the first patients, marking a key milestone on the path toward the registration of our medical device.